Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) EPS (Basic) (2020 - 2025)

Maxcyte (MXCT) has disclosed EPS (Basic) for 6 consecutive years, with -$0.09 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 10.0% to -$0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.43 through Dec 2025, down 10.26% year-over-year, with the annual reading at -$0.42 for FY2025, 7.69% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.09 at Maxcyte, up from -$0.12 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.03 in Q3 2021, with the low at -$0.12 in Q2 2025.
  • Average EPS (Basic) over 5 years is -$0.08, with a median of -$0.09 recorded in 2021.
  • The sharpest move saw EPS (Basic) surged 55.56% in 2022, then tumbled 175.0% in 2023.
  • Over 5 years, EPS (Basic) stood at -$0.05 in 2021, then fell by 0.0% to -$0.05 in 2022, then increased by 0.0% to -$0.05 in 2023, then tumbled by 100.0% to -$0.1 in 2024, then increased by 10.0% to -$0.09 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.09, -$0.12, and -$0.12 for Q4 2025, Q3 2025, and Q2 2025 respectively.